ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response

[1]  S. Goldman,et al.  Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs , 2020, Advanced science.

[2]  Silva Kasela,et al.  Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells , 2020, Cell.

[3]  A. Helenius,et al.  Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.

[4]  Li Li,et al.  When glia meet induced pluripotent stem cells (iPSCs) , 2020, Molecular and Cellular Neuroscience.

[5]  Madeline A. Lancaster,et al.  SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids , 2020, Cell Stem Cell.

[6]  Jay Gopalakrishnan,et al.  SARS‐CoV‐2 targets neurons of 3D human brain organoids , 2020, The EMBO journal.

[7]  X. Mao,et al.  iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2 , 2020, ACS chemical neuroscience.

[8]  J. Chan,et al.  SARS-CoV-2 infects human neural progenitor cells and brain organoids , 2020, Cell Research.

[9]  Catherine Z. Chen,et al.  Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism , 2020, bioRxiv.

[10]  C. Svendsen,et al.  Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection , 2020, Cell Reports Medicine.

[11]  L. Smirnova,et al.  Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. , 2020, ALTEX.

[12]  S. Farhadian,et al.  Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.

[13]  P. Kane,et al.  Regulation of V-ATPase Activity and Organelle pH by Phosphatidylinositol Phosphate Lipids , 2020, Frontiers in Cell and Developmental Biology.

[14]  Duc-Huy T. Nguyen,et al.  A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids , 2020, Cell Stem Cell.

[15]  K. Blennow,et al.  Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19 , 2020, Neurology.

[16]  Pardis C Sabeti,et al.  Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.

[17]  S. Chanda,et al.  Sofosbuvir protects human brain organoids against SARS-CoV-2 , 2020, bioRxiv.

[18]  Bin Zhang,et al.  CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes , 2020, Neuron.

[19]  Victor G. Puelles,et al.  Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[20]  Cezmi A Akdis,et al.  Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19 , 2020, Allergy.

[21]  D. Melzer,et al.  APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort , 2020, medRxiv.

[22]  Marco Tullio Liuzza,et al.  More than smell – COVID-19 is associated with severe impairment of smell, taste, and chemesthesis , 2020, medRxiv.

[23]  J. Sejvar,et al.  Neurological associations of COVID-19 , 2020, The Lancet Neurology.

[24]  M. Fowkes,et al.  Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) , 2020, Journal of medical virology.

[25]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[26]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[27]  Q. Ye,et al.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.

[28]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[29]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[30]  Giuliano Rizzardini,et al.  Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[31]  F. Gage,et al.  Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids , 2020, Cell reports. Medicine.

[32]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[33]  Catherine M. Brown,et al.  First 12 patients with coronavirus disease 2019 (COVID-19) in the United States , 2020, medRxiv.

[34]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[35]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[36]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[37]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[38]  R. Zorec,et al.  Astrocytes in Flavivirus Infections , 2019, International journal of molecular sciences.

[39]  Neville E. Sanjana,et al.  GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. , 2018, Cell stem cell.

[40]  L. Tsai,et al.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.

[41]  Elizabeta Gjoneska,et al.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.

[42]  W. Banks,et al.  Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions , 2018, Pharmacological Reviews.

[43]  A. Fagan,et al.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy , 2017, Nature.

[44]  Shinya Yamanaka,et al.  Induced pluripotent stem cell technology: a decade of progress , 2016, Nature Reviews Drug Discovery.

[45]  David W. Nauen,et al.  Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure , 2016, Cell.

[46]  R. Jaenisch,et al.  Induced Pluripotent Stem Cells Meet Genome Editing. , 2016, Cell stem cell.

[47]  William A. Lee,et al.  Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.

[48]  Jürgen Winkler,et al.  Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. , 2015, Cell stem cell.

[49]  Elsa Vera,et al.  Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. , 2015, Cell stem cell.

[50]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[51]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[52]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[53]  F. Gage,et al.  Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. , 2011, Human molecular genetics.

[54]  R. Tanzi,et al.  Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses , 2008, Nature Reviews Neuroscience.

[55]  M. Katze,et al.  Genomic Analysis Reveals Age-Dependent Innate Immune Responses to Severe Acute Respiratory Syndrome Coronavirus , 2008, Journal of Virology.

[56]  Jeff E. Mold,et al.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression , 2008, Proceedings of the National Academy of Sciences.

[57]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[58]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[59]  J. Burgos,et al.  Effect of Apolipoprotein E on the Cerebral Load of Latent Herpes Simplex Virus Type 1 DNA , 2006, Journal of Virology.

[60]  B. Hyman,et al.  Endocytic Pathway Abnormalities Precede Amyloid β Deposition in Sporadic Alzheimer’s Disease and Down Syndrome , 2000 .

[61]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[62]  Li Li,et al.  Modeling neurological diseases using iPSC-derived neural cells , 2017, Cell and Tissue Research.

[63]  F. Gage,et al.  Orphan nuclear receptor TLX activates Wnt/β-catenin signalling to stimulate neural stem cell proliferation and self-renewal , 2010, Nature Cell Biology.

[64]  F. Gage,et al.  Expression and function of orphan nuclear receptor TLX in adult neural stem cells , 2004, Nature.